Heliospectra - Major growth opportunities ahead
2021-09-02 10:00:00
Redeye remains positive on the case as we see Heliospectra very well positioned to benefit from the long-term growth trends in the Aghort industry. Business has been impacted by the global pandemic and we now expect a general recovery in the market as conditions are improving. A stronger sales organization and improved offering, including the launch of biosensor systems in 2022, will in our view give excellent growth opportunities.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/